Argos Therapeutics' Series E Round

Argos Therapeutics raised a round of funding on August 26, 2013.

Argos Therapeutics, formerly Merix Bioscience, s a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infe…

Articles about Argos Therapeutics' Series E Round: